682 related articles for article (PubMed ID: 20614461)
21. Hyperbaric oxygenation for tumour sensitisation to radiotherapy.
Bennett MH; Feldmeier J; Smee R; Milross C
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD005007. PubMed ID: 29637538
[TBL] [Abstract][Full Text] [Related]
22. A comparative analysis of overall survival between high-dose-rate and low-dose-rate brachytherapy boosts for unfavorable-risk prostate cancer.
King MT; Yang DD; Muralidhar V; Mahal B; Butler S; Devlin PM; Lee LJ; Mouw KW; Martin NM; D'Amico AV; Nguyen PL; Orio PF
Brachytherapy; 2019; 18(2):186-191. PubMed ID: 30638912
[TBL] [Abstract][Full Text] [Related]
23. CT based three dimensional dose-volume evaluations for high-dose rate intracavitary brachytherapy for cervical cancer.
Murakami N; Kasamatsu T; Wakita A; Nakamura S; Okamoto H; Inaba K; Morota M; Ito Y; Sumi M; Itami J
BMC Cancer; 2014 Jun; 14():447. PubMed ID: 24938757
[TBL] [Abstract][Full Text] [Related]
24. A Randomized Controlled Trial Comparing Clinical Outcomes and Toxicity of Lobaplatin- Versus Cisplatin-Based Concurrent Chemotherapy Plus Radiotherapy and High-Dose-Rate Brachytherapy for FIGO Stage II and III Cervical Cancer.
Wang JQ; Wang T; Shi F; Yang YY; Su J; Chai YL; Liu Z
Asian Pac J Cancer Prev; 2015; 16(14):5957-61. PubMed ID: 26320479
[TBL] [Abstract][Full Text] [Related]
25. High dose rate versus low dose rate brachytherapy for oral cancer--a meta-analysis of clinical trials.
Liu Z; Huang S; Zhang D
PLoS One; 2013; 8(6):e65423. PubMed ID: 23762369
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of helical tomotherapy combined with CT-guided three-dimensional intracavitary brachytherapy in treatment of locally advanced cervical cancer.
Ye X; Ye P; Zheng Y; Xia W
J BUON; 2021; 26(4):1298-1305. PubMed ID: 34564984
[TBL] [Abstract][Full Text] [Related]
27. A Comparative Study of Clinical Outcomes in Locally Advanced Cervical Cancer: External Beam Radiotherapy (EBRT) and Sequential High Dose Rate Intracavitary Brachytherapy (HDRICBT) with or without Concurrent Cisplatin on the Day of ICBT Insertion - A Tertiary Care Center Randomized Controlled Trial in India.
Alim S; Siddiqui SA; Akram M; Hakim S; Khan MA
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1333-1338. PubMed ID: 38679994
[TBL] [Abstract][Full Text] [Related]
28. Retrospective DVH analysis of point A based intracavitary brachytherapy for uterine cervical cancer.
Someya M; Hasegawa T; Tsuchiya T; Kitagawa M; Gocho T; Fukushima Y; Hori M; Miura K; Takada Y; Nakata K; Sakata KI
J Radiat Res; 2020 Mar; 61(2):265-274. PubMed ID: 32009177
[TBL] [Abstract][Full Text] [Related]
29. Preliminary report of a single-channel applicator in high dose rate afterloading brachytherapy for cervical cancer.
Li D; Wen E; Zhang Y; Wu Z; Pang H; Ren P; Shang C; He L; Zhang J; Xiang L; Yang H; Liu Q; Wen Q; Fan J; Lin S; Wu J
Cancer Sci; 2018 Dec; 109(12):3953-3961. PubMed ID: 30353607
[TBL] [Abstract][Full Text] [Related]
30. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER).
Valle LF; Lehrer EJ; Markovic D; Elashoff D; Levin-Epstein R; Karnes RJ; Reiter RE; Rettig M; Calais J; Nickols NG; Dess RT; Spratt DE; Steinberg ML; Nguyen PL; Davis BJ; Zaorsky NG; Kishan AU
Eur Urol; 2021 Sep; 80(3):280-292. PubMed ID: 33309278
[TBL] [Abstract][Full Text] [Related]
31. Appropriate Methodology for EBRT and HDR Intracavitary/Interstitial Brachytherapy Dose Composite and Clinical Plan Evaluation for Patients With Cervical Cancer.
Xu Z; Traughber BJ; Fredman E; Albani D; Ellis RJ; Podder TK
Pract Radiat Oncol; 2019 Nov; 9(6):e559-e571. PubMed ID: 31238167
[TBL] [Abstract][Full Text] [Related]
32. A case report of a patient with bulky uterine cervical neoplasm who achieved complete response with "intentional internal high-dose policy" high-dose-rate interstitial brachytherapy.
Kashihara T; Kobayashi K; Iijima K; Murakami N; Yoshida K; Okuma K; Nakamura S; Takahashi K; Inaba K; Igaki H; Nakayama Y; Kato T; Uno T; Itami J
Medicine (Baltimore); 2020 Jul; 99(27):e20860. PubMed ID: 32629674
[TBL] [Abstract][Full Text] [Related]
33. Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: A single-institution study.
Umezawa R; Murakami N; Nakamura S; Wakita A; Okamoto H; Tsuchida K; Kashihara T; Kobayashi K; Harada K; Takahashi K; Inaba K; Ito Y; Igaki H; Masui K; Yoshida K; Jingu K; Tselis N; Itami J
Brachytherapy; 2018; 17(2):368-376. PubMed ID: 29275869
[TBL] [Abstract][Full Text] [Related]
34. Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma.
Lutgens L; van der Zee J; Pijls-Johannesma M; De Haas-Kock DF; Buijsen J; Mastrigt GA; Lammering G; De Ruysscher DK; Lambin P
Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD006377. PubMed ID: 20238344
[TBL] [Abstract][Full Text] [Related]
35. An Asian multi-national multi-institutional retrospective study comparing intracavitary versus the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical carcinoma.
Murakami N; Ando K; Murata M; Murata K; Ohno T; Aoshika T; Kato S; Okonogi N; Saito AI; Kim JY; Yoshioka Y; Sekii S; Tsujino K; Lowanichkiattikul C; Pattaranutaporn P; Kaneyasu Y; Nakagawa T; Watanabe M; Uno T; Umezawa R; Jingu K; Kanemoto A; Wakatsuki M; Shirai K; Igaki H; Itami J
J Radiat Res; 2022 May; 63(3):412-427. PubMed ID: 35446962
[TBL] [Abstract][Full Text] [Related]
36. Treatment outcomes of high-dose-rate intracavitary brachytherapy for cervical cancer: a comparison of Ir-192 versus Co-60 sources.
Tantivatana T; Rongsriyam K
J Gynecol Oncol; 2018 Sep; 29(5):e86. PubMed ID: 30049023
[TBL] [Abstract][Full Text] [Related]
37. The Impact of High-Dose-Rate Brachytherapy: Measuring Clinical Outcomes in the Primary Treatment of Cervical Cancer.
Song J; Alyamani N; Bhattacharya G; Le T; E C; Samant R
Adv Radiat Oncol; 2020; 5(3):419-425. PubMed ID: 32529136
[TBL] [Abstract][Full Text] [Related]
38. High Dose Rate Brachytherapy in Two 9 Gy Fractions in the Treatment of Locally Advanced Cervical Cancer - a South Indian Institutional Experience.
Ghosh S; Rao PB; Kotne S
Asian Pac J Cancer Prev; 2015; 16(16):7167-70. PubMed ID: 26514507
[TBL] [Abstract][Full Text] [Related]
39. Comparisons between the KKU-model and conventional rectal tubes as markers for checking rectal doses during intracavitary brachytherapy of cervical cancer.
Padoongcharoen P; Krusun S; Palusuk V; Pesee M; Supaadirek C; Thamronganantasakul K
Asian Pac J Cancer Prev; 2014; 15(15):6115-20. PubMed ID: 25124583
[TBL] [Abstract][Full Text] [Related]
40. LDR brachytherapy offers superior tumor control to single-fraction HDR prostate brachytherapy: A prospective study.
Jimenez-Garcia IE; Sabater S; Martinez-Gutierrez R; Sanchez-Galiano P; Berenguer-Serrano R; Castro-Larefors S; Rey-Lopez I; Ruiz-Herrero B; Sánchez-Prieto R; Rovirosa A; Arenas M; Gonzalez-Suarez HA
Prostate; 2023 Aug; 83(11):1068-1075. PubMed ID: 37150842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
